Herzing NU 670 Unit 8 Discussion Latest
Just Click on Below Link To Download This Course:
https://www.coursetutor.us/product/herzing-nu-670-unit-8-discussion-latest/
Herzing NU 670 Unit 8 Discussion Latest
Unit 8 Discussion
Reflection
Please respond to the following questions based upon
these course objectives:
- Understand and be able to articulate the fundamentals of
neurotransmission as it relates to prescribing psychotropic medications
for clients with acute and chronic mental health conditions.
- Discuss major categories of psychotropic drugs, their rationale for
use, mechanisms of action, common side effects, and drug interactions.
- Discuss evidence to support and the appropriate use of
complimentary alternative medications in patients that are experiencing
acute and chronic mental health conditions seeking adjunctive or
monotherapy treatment while considering cultural and genetic factors as
well as patient values.
- Utilize clinical assessment tools associated with diagnosing and
prescribing for psychiatric disorders and begin to utilize these tools in
clinical settings to assist with diagnosis and treatment of chronic mental
health conditions.
- Propose psychotherapeutic medication for selected patients keeping
in mind safety concerns while utilizing knowledge of current mental
health, medical concerns, age, gender, cultural factors, genetic factors,
ethical concerns, patient values, and prescriptive authority impact
decision making.
- Utilize research and provide basic diagnostic and
psychopharmacology education to your client and his/her family when
prescribing.
- Understand ethical and legal considerations and
controversies in current pharmacological treatment of mental health
patients.
Please answer the following questions with supporting
examples and full explanations.
- For each of the learning objectives, provide an analysis of how the
course supported each objective.
- Explain how the material learned in this course,
based upon the objectives, will be applicable to the professional
application.


Comments
Post a Comment